The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis

Hematology
Pingli YaoHongtao Xiao

Abstract

The effect of methotrexate (MTX)-related adverse reaction on hematologic neoplasms patients is controversial. We performed this meta-analysis to assess the association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphism and the adverse reaction after MTX using. We searched for qualified studies according to PubMed, the Cochrane Library, and the Web of Science. The meta-analysis was performed by Review Manager 5.3. The analysis was conducted to compare risk ratios (RRs) with the corresponding 95% confidence interval (95% CI) to evaluate the relationship between different toxicity reactions and the genotype of MTHFR. We included 17 studies which satisfied with the criteria in this meta-analysis. The results of our statistical analysis showed that no significant correlation between MTHFR C677T/A1298C genetic polymorphism and patients' toxicity or the relapse and survival associated with MTX chemotherapy (P > .05). But we observed that a tendency toward increased risk of hepatotoxicity was also present for acute lymphoblastic leukemia in the mutation model (CT/TT vs. CC: RR: 1.92, 95% CI: 1.01-3.67; P = .05). The polymorphism of MTHFR C677T/A1298C may not be an important indicator for the accurate detectio...Continue Reading

References

Aug 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M V RellingW E Evans
Feb 26, 2008·Leukemia & Lymphoma·Alan Kambiz Fotoohi, Freidoun Albertioni
Jun 26, 2009·The New England Journal of Medicine·Ching-Hon PuiMary V Relling
Nov 20, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Azza A G TantawyEsmat E Abdulghaffar
Jul 31, 2010·Pediatric Hematology and Oncology·Masanori HorinouchiTsutomu Nakamura
Dec 2, 2010·Genetic Testing and Molecular Biomarkers·Nikolaos V KarathanasisMaria Kalmanti
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ching-Hon PuiRobert J Arceci
May 28, 2011·Pediatric Blood & Cancer·Dana M SepeRichard Aplenc
Apr 25, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lin YangLuhang Xu
Mar 7, 2014·European Journal of Haematology·Mona W AyadMostafa El Naggar
Aug 12, 2014·Leukemia & Lymphoma·Hilda Verónica AráozMarisa Felice

❮ Previous
Next ❯

Citations

Dec 14, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Rim FrikhaNouha Bouayed
Feb 2, 2019·Current Drug Metabolism·Guillermo Gervasini, Sonia Mota-Zamorano
Sep 1, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Rim FrikhaTarek Rebai
Nov 26, 2020·Therapeutic Drug Monitoring·Smita PattanaikJasmina Ahluwalia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.